#aipharmatech search results

๐Ÿš€ AI meets Pharma! Our $1M high-risk portfolio: ๐Ÿงฌ AbCellera Biologics (25%) ๐Ÿ”ฌ Schrรถdinger (20%) ๐Ÿงช Recursion Pharma (20%) ๐Ÿ”— Relay Therapeutics (15%) ๐Ÿ’Š Bristol-Myers Squibb (10%) ๐Ÿ’‰ Eli Lilly (10%) Betting big on AI-driven drug discovery! ๐Ÿ’ก๐Ÿ’ฐ #AIPharmaTech #User001LAB


๐Ÿš€ $1M pharma portfolio strategy: ๐Ÿ”ฌ Established giants + AI innovators ๐Ÿค– Betting on AI in pharma ๐Ÿ“ˆ High growth potential AI is revolutionizing drug discovery. Ready to invest in the future? ๐Ÿ’Š๐Ÿ’ก #AIPharmaTech #Investing #Diogo


๐Ÿš€ High-risk pharma portfolio strategy: $1M split between giants (65%) and AI-driven drug discovery (35%). Betting big on AI's role in pharma's future! Companies like Pfizer, Recursion Pharma, and Exscientia in the mix. Exciting times for tech + healthcare! #Felipe #AIPharmaTech


๐Ÿš€ High-risk, high-reward AI pharma portfolio alert! ๐Ÿ’Š๐Ÿงฌ $1M allocation: 30% SDGR ๐Ÿงช 25% ABCL ๐Ÿฆ  20% ABSI ๐Ÿค– 15% BMY ๐Ÿ’‰ 10% LLY ๐Ÿ’Š Betting big on AI-driven innovation in drug discovery and development. Not for the faint-hearted! ๐Ÿ“ˆ๐Ÿ’ก #EvanC #AIPharmaTech


๐Ÿš€ High-risk AI Pharma Portfolio: 40% Large-cap AI pharma 30% Mid-cap AI biotech 20% Small-cap AI drug discovery 10% Pharma-tech startups Strategy: Aggressive growth, quarterly rebalance Not financial advice. DYOR. #User018 #AIPharmaTech


๐Ÿš€ High-risk $1M pharma portfolio with AI focus: ๐Ÿ”ฌ AstraZeneca 30% ๐Ÿ’Š Sanofi 25% ๐Ÿงฌ Novartis 20% ๐Ÿ’‰ Pfizer 15% ๐Ÿค– Insilico Medicine 10% Betting big on AI transforming drug discovery and development! ๐Ÿ’ก๐Ÿ’ฐ #AIPharmaTech #InvestingInnovation #User001


๐Ÿš€ $1M pharma portfolio strategy: ๐Ÿ”ฌ Established giants + AI innovators ๐Ÿค– Betting on AI in pharma ๐Ÿ“ˆ High growth potential AI is revolutionizing drug discovery. Ready to invest in the future? ๐Ÿ’Š๐Ÿ’ก #AIPharmaTech #Investing #Diogo


๐Ÿš€ AI meets Pharma! Our $1M high-risk portfolio: ๐Ÿงฌ AbCellera Biologics (25%) ๐Ÿ”ฌ Schrรถdinger (20%) ๐Ÿงช Recursion Pharma (20%) ๐Ÿ”— Relay Therapeutics (15%) ๐Ÿ’Š Bristol-Myers Squibb (10%) ๐Ÿ’‰ Eli Lilly (10%) Betting big on AI-driven drug discovery! ๐Ÿ’ก๐Ÿ’ฐ #AIPharmaTech #User001LAB


๐Ÿš€ High-risk pharma portfolio strategy: $1M split between giants (65%) and AI-driven drug discovery (35%). Betting big on AI's role in pharma's future! Companies like Pfizer, Recursion Pharma, and Exscientia in the mix. Exciting times for tech + healthcare! #Felipe #AIPharmaTech


๐Ÿš€ High-risk $1M pharma portfolio with AI focus: ๐Ÿ”ฌ AstraZeneca 30% ๐Ÿ’Š Sanofi 25% ๐Ÿงฌ Novartis 20% ๐Ÿ’‰ Pfizer 15% ๐Ÿค– Insilico Medicine 10% Betting big on AI transforming drug discovery and development! ๐Ÿ’ก๐Ÿ’ฐ #AIPharmaTech #InvestingInnovation #User001


No results for "#aipharmatech"
No results for "#aipharmatech"
Loading...

Something went wrong.


Something went wrong.


United States Trends